Trump Is Being Sued For Rescheduling Marijuana By Doctors And A Pharmaceutical Company Who Are ‘Aggrieved’ By The Move
A coalition of doctors, substance misuse professionals, and a cannabis-focused biopharmaceutical company has filed a lawsuit against President Trump and administration officials challenging the federal rescheduling of marijuana. The plaintiffs claim the rescheduling action violated administrative procedures by lacking prior notice-and-comment requirements.
Filed under Court Ruling in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
Hemp Companies Sue DEA, Challenging Agency’s Claim That Synthetic Cannabis Compound HHC Is Federally Banned
DOJ rethinks cannabis & gun prosecutions (Newsletter: May 1, 2026)
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Minnesota hemp retailers challenge new ban on mail-order THC edible sales
Stay current on Minnesota cannabis
Browse more court ruling updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.